Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | Not yet disclosed by govt. | 15 | - |
| 2 | Schedule 2 | Not yet disclosed by govt. | 15 | - |
| 3 | Schedule 3 | Not yet disclosed by govt. | 15 | - |
| 4 | Schedule 4 | Not yet disclosed by govt. | 15 | - |
| 5 | Schedule 5 | Not yet disclosed by govt. | 15 | - |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
22 May 2024, 3:00 pmClosed
SACUBITRAIL (49MG) + VALSARTAN (51MG) TAB (Q3)
SYP COUGH EXPECTORANT 100 ML (Q3)
DONEPEZIL 10 MG TAB (Q3)
TORSEMIDE 20 MG TAB (Q3)
GLIMEPRIDE 2 MG+ METFORMIN 1000 MG SR TAB (Q3)
MIRABEGRON 50 MG TAB (Q3)
LINAGLIPTIN 5 MG+ METFORMIN 1000 MG TAB (Q3)
PANTAPRAZOLE 40 MG+ LEVOSULPIRIDE 75 MG CAP (Q3)
ALPHA LIPOIC ACID+ CHROMIUM+ FOLIC ACID METHYLCOBALMIN+ SELENIUM+ ZINC (Q3)
GLUCOSAMINE 500 MG+ DIACERIN 50 MG TAB (Q3)
PANTAPROZOLE 40 MG+ DOMPERIDONE 10 MG (PAN D) (Q3)
SYRINGE DISPO PLASTIC 3 ML WITH NEEDLE (Q3)
CEFUROXIME 500 MG TAB (Q3)
GLUCOSAMINE 750 MG+ DIACERINE 50 MG+ MSM 200 MG TAB (Q3)
ACECLOFENAC 100+ PARACETAMOL 325+ CHLOROXAZONE 250 TAB (Q3)
DICLOFENAC GEL OF 10 GM (Q3)
SYP LACTULOSE 200 ML (Q3)
6337933
GEM/2024/B/4884670
Two Packet Bid
SACUBITRAIL (49MG) + VALSARTAN (51MG) TAB,SYP COUGH EXPECTORANT 100 ML,DONEPEZIL 10 MG TAB,TORSEMID
30 days
Punjab; Jalandhar
Item wise evaluation
PRODUCT_CUSTOM
7 documents required · 7 mandatory
3 yrs
₹3
80%
| Item | Delivery Location | Qty | Delivery | Spec |
|---|---|---|---|---|
| SACUBITRAIL (49MG) + VALSARTAN (51MG) TAB (Q3) | JALANDHAR | 20,520 | 30 days | |
| SYP COUGH EXPECTORANT 100 ML (Q3) | JALANDHAR | 15,390 | 30 days | |
| DONEPEZIL 10 MG TAB (Q3) | JALANDHAR | 6,450 | 30 days | |
| TORSEMIDE 20 MG TAB (Q3) | JALANDHAR | 88,350 | 30 days | |
| GLIMEPRIDE 2 MG+ METFORMIN 1000 MG SR TAB (Q3) | JALANDHAR | 165,600 | 30 days | |
| MIRABEGRON 50 MG TAB (Q3) | JALANDHAR | 14,700 | 30 days | |
| LINAGLIPTIN 5 MG+ METFORMIN 1000 MG TAB (Q3) | JALANDHAR | 8,700 | 30 days | |
| PANTAPRAZOLE 40 MG+ LEVOSULPIRIDE 75 MG CAP (Q3) | JALANDHAR | 100,200 | 30 days | |
| ALPHA LIPOIC ACID+ CHROMIUM+ FOLIC ACID METHYLCOBALMIN+ SELENIUM+ ZINC (Q3) | JALANDHAR | 49,500 | 30 days | |
| GLUCOSAMINE 500 MG+ DIACERIN 50 MG TAB (Q3) | JALANDHAR | 96,000 | 30 days | |
| PANTAPROZOLE 40 MG+ DOMPERIDONE 10 MG (PAN D) (Q3) | JALANDHAR | 306,600 | 30 days | |
| SYRINGE DISPO PLASTIC 3 ML WITH NEEDLE (Q3) | JALANDHAR | 7,650 | 30 days | |
| CEFUROXIME 500 MG TAB (Q3) | JALANDHAR | 22,500 | 30 days | |
| GLUCOSAMINE 750 MG+ DIACERINE 50 MG+ MSM 200 MG TAB (Q3) | JALANDHAR | 38,400 | 30 days | |
| ACECLOFENAC 100+ PARACETAMOL 325+ CHLOROXAZONE 250 TAB (Q3) | JALANDHAR | 76,500 | 30 days | |
| DICLOFENAC GEL OF 10 GM (Q3) | JALANDHAR | 26,550 | 30 days | |
| SYP LACTULOSE 200 ML (Q3) | JALANDHAR | 6,750 | 30 days |
Exempted
22 May 2024
1 May 2024
22 May 2024
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_6337933.pdf
GEM_BID
re-09_detail_2024-04-24-09-58-42_14b5377bd13b4011ff7dfd1800deb871.pdf
SPECIFICATION
re-09_detail_2024-04-24-09-59-05_bf8cfbc6aaea21007c6c15fc4ff23f78.pdf
SPECIFICATION
re-09_detail_2024-04-24-10-02-29_90709d6ddae3aa746a0bbbe68a9fe3d1.pdf
SPECIFICATION
re-09_detail_2024-04-24-10-02-51_0fa0b7a0165883913ee8734c7314ce8b.pdf
SPECIFICATION
re-09_detail_2024-04-24-10-03-12_b951530539cec7763144e8b9bba5d176.pdf
SPECIFICATION
re-09_detail_2024-04-24-10-03-35_1c6bc28aaf4a856932102c2cd5e1ef0f.pdf
SPECIFICATION
re-09_detail_2024-04-24-10-03-56_530784522dacef49952340c0f11511a0.pdf
SPECIFICATION
re-09_detail_2024-04-24-10-04-16_223e90085cb612a231f087e368619135.pdf
SPECIFICATION
re-09_detail_2024-04-24-10-04-35_8a6b0bc25a4f4dc971ae87339071846f.pdf
SPECIFICATION
re-09_detail_2024-04-24-10-04-54_70c977fdfe51b6817389fa9c7903952d.pdf
SPECIFICATION
re-09_detail_2024-04-24-10-08-53_451fa10474a57daafb1aae5df6ad94c9.pdf
SPECIFICATION
re-09_detail_2024-04-24-10-09-53_c389e60f89cbda0647ea6de7e87c4383.pdf
SPECIFICATION
re-09_detail_2024-04-24-10-10-22_2c32c1eaff0563107f6eb6e7a92da654.pdf
SPECIFICATION
re-09_detail_2024-04-24-10-10-46_3350b924d226db4759976faa67d2b69f.pdf
SPECIFICATION
re-09_detail_2024-04-24-10-11-07_af8be8e7d5bad41055ffa59a5609f60d.pdf
SPECIFICATION
re-09_detail_2024-04-24-10-14-17_3763197e98d3a567395b6ee28934cc31.pdf
SPECIFICATION
re-09_detail_2024-04-24-10-14-39_472457d32f56704b6a526c8e0858c698.pdf
SPECIFICATION
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .